文献速递肝病

肝硬化中色氨酸-犬尿氨酸通路、急性失代偿与慢加急性肝衰竭的协同作用

Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.
PubMed 文献 · Hepatology · 2019-03-19

研究测定了40名健康者、39例代偿期肝硬化、342例急性失代偿(无ACLF)和180例ACLF患者的血清色氨酸及犬尿氨酸通路代谢物与细胞因子,并在258例患者28天随访中复测。结果示该通路活性在代偿期正常、急性失代偿时升高、ACLF时进一步升高,且与肾衰竭、临床病程、感染及死亡率相关。

要点

  • 血清犬尿氨酸通路活性在代偿期肝硬化正常,急性失代偿时升高,ACLF时进一步升高。
  • ACLF合并肾衰竭者血清通路活性显著高于无肾衰竭者,尿通路活性及分数排泄无差异。
  • 基线通路活性最高者随访中易发生ACLF、院内感染,且独立预测死亡率。

核心结论

  • 色氨酸-犬尿氨酸通路激活特征出现于急性失代偿患者,在ACLF患者中达高峰,可能参与ACLF的发病、临床病程和死亡率。

研究设计与样本

  • 研究纳入40名健康者、39例代偿期肝硬化、342例急性失代偿(无ACLF)和180例ACLF患者,测定血清色氨酸、关键犬尿氨酸通路代谢物及细胞因子,并在258例患者28天随访中复测。
  • 对50例ACLF患者测定尿犬尿氨酸通路代谢物。

主要发现

  • 血清犬尿氨酸通路活性在代偿期肝硬化正常,急性失代偿时升高,ACLF时进一步升高,与全身炎症平行。
  • ACLF合并肾衰竭者血清通路活性显著高于无肾衰竭者,而尿通路活性及代谢物分数排泄无差异。
  • 急性失代偿和ACLF的短期病程(恶化、改善、稳定)与随访中血清通路活性变化密切相关。
  • 基线通路活性最高的急性失代偿患者随访中发生ACLF;基线有免疫抑制且通路活性最高的ACLF患者随访中发生院内感染。
  • 较高的基线通路活性独立预测急性失代偿和ACLF患者的死亡率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Systemic inflammation (SI) is involved in the pathogenesis of acute decompensation (AD) and acute-on-chronic liver failure (ACLF) in cirrhosis. In other diseases, SI activates tryptophan (Trp) degradation through the kynurenine pathway (KP), giving rise to metabolites that contribute to multiorgan/system damage and immunosuppression. In the current study, we aimed to characterize the KP in patients with cirrhosis, in whom this pathway is poorly known. The serum levels of Trp, key KP metabolites (kynurenine and kynurenic and quinolinic acids), and cytokines (SI markers) were measured at enrollment in 40 healthy subjects, 39 patients with compensated cirrhosis, 342 with AD (no ACLF) and 180 with ACLF, and repeated in 258 patients during the 28-day follow-up. Urine KP metabolites were measured in 50 patients with ACLF. Serum KP activity was normal in compensated cirrhosis, increased in AD and further increased in ACLF, in parallel with SI; it was remarkably higher in ACLF with kidney failure than in ACLF without kidney failure in the absence of differences in urine KP activity and fractional excretion of KP metabolites. The short-term course of AD and ACLF (worsening, improvement, stable) correlated closely with follow-up changes in serum KP activity. Among patients with AD at enrollment, those with the highest baseline KP activity developed ACLF during follow-up. Among patients who had ACLF at enrollment, those with immune suppression and the highest KP activity, both at baseline, developed nosocomial infections during follow-up. Finally, higher baseline KP activity independently predicted mortality in patients with AD and ACLF. Conclusion: Features of KP activation appear in patients with AD, culminate in patients with ACLF, and may be involved in the pathogenesis of ACLF, clinical course, and mortality.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Clària J, Moreau R, Fenaille F, et al. Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis. Hepatology. 2019. PMID: 30521097. doi:10.1002/hep.30363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。